Results 161 to 170 of about 775,328 (297)

Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?

, 2002
Válerie de Haas, Gertjan J.L. Kaspers, Liesbeth E.M. Oosten, Dorine Bresters, R. Pieters, Vincent H. J. van der Velden, Elisabeth R. van Wering, Henk van den Berg, C. Ellen van der Schoot   +8 more
openalex   +2 more sources

Minimal residual disease in solid tumors: Clinical applications and future directions. [PDF]

Cancer
Abdo T, Alhalabi A, Yaghi S, Aloran M, Li Y, Herrán M, Tfayli R, Samuel TA, Nahleh Z.   +8 more
europepmc   +1 more source

P470: NGS-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PERIPHERAL BLOOD SHOWS GOOD PROGNOSTIC VALUE FOR OS AND EFS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECRUITED IN THE UNIFY TRIAL

, 2022
Christian Thiede, C. Schuster, C. Krippendorf, G. Koenen, T. Medts, P. Marques Ramos, L. Gou, Pau Montesinos, W. Fiedler, R. Müller, J. Krauter, S. Sica, J. Westermann, M. Levis, R. Stone, Juan Felipe Trujillo Sierra, H. Döhner   +16 more
openalex   +1 more source

Chemotherapy-Free Achievement of Minimal Residual Disease in a Jehovah's Witness Patient With Ph-Negative B-ALL. [PDF]

Am J Case Rep
Koilpillai S, Altaf R, El Barche Palmera A, Hassanein H, Carlan SJ.   +4 more
europepmc   +1 more source

Highs and lows of minimal residual disease in CLL [PDF]

, 2019
Deborah M. Stephens
openalex   +1 more source

Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma. [PDF]

Target Oncol
Gan X, Li L, Zhang L, Zheng Y, Niu T, Yu Z.   +5 more
europepmc   +1 more source

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? [PDF]

, 2019
Cripe, James C, Fuh, Katherine C, Litz, Taylor, Lopez, Heather, Mills, Kathryn A, Mutch, David G, Powell, Matthew A, Sun, Lulu, Thaker, Premal H   +8 more
core   +1 more source

Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma [PDF]

, 2015
Nicole Gormley, Danielle M. Turley, Jennifer S. Dickey, Ann T. Farrell, Gregory H. Reaman, Elizabeth A. Stafford, Lea Carrington, Gerald E. Marti   +7 more
openalex   +1 more source

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

Blood, 2018
G. Schuurhuis, M. Heuser, S. Freeman, M. Béné, F. Buccisano, J. Cloos, D. Grimwade, T. Haferlach, R. Hills, C. Hourigan, J. Jorgensen, W. Kern, F. Lacombe, L. Maurillo, C. Preudhomme, B. A. van der Reijden, C. Thiede, A. Venditti, P. Vyas, B. Wood, R. Walter, K. Döhner, G. Roboz, G. Ossenkoppele   +23 more
semanticscholar   +1 more source

Minimal residual disease in ALL [PDF]

Nature Reviews Clinical Oncology, 2010
openaire   +2 more sources